Catalent Inc at Jefferies Healthcare Conference Transcript

Jun 06, 2019 / 07:00PM GMT
David Howard Windley - Jefferies LLC, Research Division - Equity Analyst

All right. Good afternoon. Hello, everybody. I'm Dave Windley with Jefferies Healthcare Equity Research. Thank you for being here at our 2019 Global Healthcare Conference in New York. Our next presenting company is Catalent, ticker CTLT. Here to talk to us about Catalent -- we're going to do a little fireside chat here, but here with me on the stage is Wetteny Joseph, the company's Chief Financial Officer; and Tom Castellano, the company's VP of Finance. He's got multiple hats: VP of Finance, IR, Treasurer. So thank you both to you guys for being here.

So Wetteny, just to start, we, I think, know that Catalent is a CDMO, but it has been kind of transforming itself through number of transactions over the last couple of years. Why don't you kind of layout that transformation for us?

Wetteny N. Joseph - Catalent, Inc. - Senior VP & CFO

Yes, sure. So for those of you who are new to the Catalent name, we are the leader in advanced delivery dosage forms and development solutions. Our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot